A detailed history of Capital Research Global Investors transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Capital Research Global Investors holds 1,304,615 shares of IART stock, worth $28.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,304,615
Previous 2,428,609 46.28%
Holding current value
$28.9 Million
Previous $70.8 Million 66.51%
% of portfolio
0.01%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$17.14 - $31.74 $19.3 Million - $35.7 Million
-1,123,994 Reduced 46.28%
1,304,615 $23.7 Million
Q2 2024

Aug 13, 2024

SELL
$23.14 - $34.72 $80.8 Million - $121 Million
-3,490,372 Reduced 58.97%
2,428,609 $70.8 Million
Q1 2024

May 14, 2024

BUY
$33.4 - $45.2 $54.2 Million - $73.3 Million
1,621,655 Added 37.74%
5,918,981 $210 Million
Q4 2023

Feb 13, 2024

BUY
$34.21 - $44.59 $42 Million - $54.8 Million
1,228,996 Added 40.05%
4,297,326 $187 Million
Q3 2023

Nov 13, 2023

SELL
$37.8 - $45.97 $7.18 Million - $8.73 Million
-189,816 Reduced 5.83%
3,068,330 $117 Million
Q2 2023

Aug 11, 2023

SELL
$37.95 - $58.98 $21.5 Million - $33.4 Million
-565,580 Reduced 14.79%
3,258,146 $134 Million
Q4 2022

Feb 14, 2023

BUY
$42.17 - $58.6 $29.6 Million - $41.2 Million
702,779 Added 22.52%
3,823,726 $214 Million
Q3 2022

Nov 14, 2022

SELL
$42.28 - $57.17 $31.7 Million - $42.8 Million
-748,823 Reduced 19.35%
3,120,947 $132 Million
Q2 2022

Aug 15, 2022

SELL
$53.86 - $66.52 $159 Million - $196 Million
-2,948,154 Reduced 43.24%
3,869,770 $209 Million
Q1 2022

May 16, 2022

SELL
$62.86 - $69.24 $88.1 Million - $97 Million
-1,401,209 Reduced 17.05%
6,817,924 $438 Million
Q4 2021

Feb 14, 2022

SELL
$62.47 - $73.25 $1.96 Million - $2.29 Million
-31,319 Reduced 0.38%
8,219,133 $551 Million
Q3 2021

Nov 15, 2021

SELL
$64.97 - $76.19 $128,445 - $150,627
-1,977 Reduced 0.02%
8,250,452 $565 Million
Q2 2021

Aug 16, 2021

BUY
$66.79 - $76.63 $1.48 Million - $1.7 Million
22,198 Added 0.27%
8,252,429 $563 Million
Q1 2021

May 14, 2021

SELL
$62.63 - $71.15 $441,541 - $501,607
-7,050 Reduced 0.09%
8,230,231 $569 Million
Q4 2020

Feb 12, 2021

SELL
$43.31 - $66.55 $31.3 Million - $48.1 Million
-722,295 Reduced 8.06%
8,237,281 $535 Million
Q3 2020

Nov 13, 2020

SELL
$43.33 - $51.72 $16.1 Million - $19.2 Million
-370,870 Reduced 3.97%
8,959,576 $423 Million
Q2 2020

Aug 14, 2020

BUY
$41.42 - $55.57 $7.31 Million - $9.81 Million
176,447 Added 1.93%
9,330,446 $438 Million
Q1 2020

May 15, 2020

BUY
$36.67 - $61.04 $1.21 Million - $2.02 Million
33,046 Added 0.36%
9,153,999 $409 Million
Q4 2019

Feb 18, 2020

BUY
$55.73 - $62.49 $3.64 Million - $4.09 Million
65,402 Added 0.72%
9,120,953 $532 Million
Q3 2019

Nov 14, 2019

BUY
$53.29 - $64.59 $20,516 - $24,867
385 Added 0.0%
9,055,551 $544 Million
Q2 2019

Aug 14, 2019

BUY
$46.45 - $55.85 $3.16 Million - $3.81 Million
68,131 Added 0.76%
9,055,166 $506 Million
Q1 2019

May 15, 2019

SELL
$42.97 - $57.33 $28.1 Million - $37.5 Million
-653,508 Reduced 6.78%
8,987,035 $501 Million
Q4 2018

Feb 14, 2019

SELL
$42.62 - $64.51 $23.3 Million - $35.2 Million
-545,675 Reduced 5.36%
9,640,543 $435 Million
Q3 2018

Nov 14, 2018

BUY
$57.63 - $65.87 $24.4 Million - $27.9 Million
423,324 Added 4.34%
10,186,218 $671 Million
Q2 2018

Aug 14, 2018

BUY
$54.05 - $67.23 $8.08 Million - $10.1 Million
149,488 Added 1.55%
9,762,894 $629 Million
Q1 2018

May 15, 2018

BUY
$46.55 - $57.38 $13,034 - $16,066
280 Added 0.0%
9,613,406 $532 Million
Q4 2017

Feb 14, 2018

BUY
$46.22 - $51.77 $164 Million - $184 Million
3,556,194 Added 58.71%
9,613,126 $460 Million
Q3 2017

Nov 14, 2017

BUY
$47.8 - $53.63 $290 Million - $325 Million
6,056,932
6,056,932 $306 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.